Development of the Gene-missile therapy against human malignant gliomas using monocyte as a carrier.
Development of the Gene-missile therapy against human malignant gliomas using monocyte as a carrier.
批准号:
09671431
负责人:
TAKESHIMA Hideo
金额:
$1.98万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998
中文摘要
人类单核细胞趋化蛋白-1受体被命名为hCCR2,是人类免疫缺陷病毒进入细胞所必需的辅助受体,也是单核细胞趋化蛋白-1的受体,单核细胞趋化蛋白-1是C-C趋化因子家族的成员,介导单核细胞趋化。为了阐明hCCR2转录调控的分子机制,我们克隆并测序了hCCR2基因,全长约8kb,由三个外显子和两个内含子组成。在5‘-侧翼区,存在典型的哺乳动物启动子共同元件,即CAAT盒和TATA盒,导致了单一的转录起始点。此外,我们还发现了成簇的组织特异性顺式调控元件,如GATA共识序列、Oct-1结合序列和CAAT/增强子结合蛋白结合序列。不同启动子缺失的荧光素酶分析和凝胶迁移率改变分析表明,THP-1细胞的基础活性需要三个位于-89到118区域的顺式调控元件。其中一个元件是TATA盒上游36-bp的八聚体序列;它主要与Oct-1结合,并能够增加转录活性。另外两个元件是CAAT/增强子结合蛋白家族的串联识别位点,位于5‘-非翻译区,解释了hCCR2的转录激活和组织特异性。
英文摘要
The human monocyte chemoattractant protein-1 receptor designated hCCR2 is an essential co-receptor in cell entry by the human immunodeficiency virus as well as a receptor for monocyte chemoattractant protein-1, a member of the family of C-C chemokines that mediate monocyte chemotaxis. To elucidate the molecular mechanisms underlying the transcriptional regulation of hCCR2, we cloned and sequenced the hCCR2 gene ; it was approximately 8 kb in length and consisted of three exons divided by two introns. In the 5'-flanking region, there were the typical mammalian promoter consensus elements, a CAAT box and a TATA box, resulting in a single transcription initiation site. In addition, we found clustered tissue-specific cis-regulatory elements such as GATA consensus sequences, Oct-1 binding sequences, and CAAT/enhancer-binding protein binding sequences. Luciferase assays with various promoter deletions and gel mobility shift assays indicated that three cis-regulatory elements located within the region from -89 to +118 are required for basal activity in THP-1 cells. One element is an octamer sequence 36-bp upstream from the TATA box ; it binds mainly to Oct-1 and is capable of increasing transcriptional activity. The other two elements, which are tandem recognition sites of the CAAT/enhancer-binding protein family, are located in the 5'-untranslated region and account for the transcriptional activation as well as the tissue specificity of hCCR2.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Takeshima,H.et al.: "Monocyte chemoattractant protein-1(MCP-1)derived from human malignant glioma.-Biological meanings of its expression and application for the treatment of malignant glioma." Research Trends. (in press). (1999)
Takeshima,H.et al.:“源自人恶性神经胶质瘤的单核细胞趋化蛋白-1(MCP-1)。-其表达的生物学意义及其在治疗恶性神经胶质瘤中的应用。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
竹島秀雄,他: "ヒト単球遊走因子受容体の発現調節機構の解明" 神経免疫研究. 10. 142-145 (1997)
Hideo Takeshima 等:“阐明人单核细胞趋化因子受体表达的调节机制”《神经免疫学研究》10. 142-145 (1997)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yamamoto,K.,Takeshima,H.,et al.: "Cloning and functional characterization of the 5'-flanking region of the human monocyte chemoattractant protein-1 receptor(CCR2)gene." J.Biol.Chem.274・8. 4646-4654 (1999)
Yamamoto, K.、Takeshima, H. 等:“人单核细胞趋化蛋白 1 受体 (CCR2) 基因 5 侧翼区域的克隆和功能表征。J.Biol.Chem.274・8” .4646-4654 (1999)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Takeshima, H., Kuratsu, J., Yamamoto, K., Nishi, T., Yamashiro, S., Ushio, Y., and Yoshimura, T.: "Monocyte chemoattractant protein-1 (MCP-1) derived from human malignant glioma. -Biological meanings of its expression and application for the treatment of
Takeshima, H.、Kuratsu, J.、Yamamoto, K.、Nishi, T.、Yamashiro, S.、Ushio, Y. 和 Yoshimura, T.:“源自人类的单核细胞趋化蛋白-1 (MCP-1)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yamamoto, K., Takeshima, H., Hamada, K., Nakao, M., Kino, T., Nishi, T., Kochi, M., Kuratsu, J., Yoshimura, T., Ushio, Y.: "Cloning and functional characterization of the 5'-flanking region of the human monocyte chemoattractant protein-1 receptor (CCR2) g
Yamamoto, K.、Takeshima, H.、Hamada, K.、Nakao, M.、Kino, T.、Nishi, T.、Kochi, M.、Kuratsu, J.、Yoshimura, T.、Ushio, Y.:
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 9 条
Identification of the novel molecular marker for oligodendroglial tumor using induced differentiation system against glioma stem cell.
-
批准号:20390387
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.56万
-
财政年份:2008
-
负责人:TAKESHIMA Hideo
-
依托单位:
Mechanisms underlying inhibition of tumor-immunology in malignant glioma and development of immune-activation therapy using suicide-chimeric molecule
-
批准号:17390405
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.5万
-
财政年份:2005
-
负责人:TAKESHIMA Hideo
-
依托单位:
Development of the clinical diagnosis and treatment of CNS germinoma using KIT as a target
-
批准号:15591536
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2003
-
负责人:TAKESHIMA Hideo
-
依托单位:
Development of chemokine-cocktail therapy against hyman malignant gliomas using lymphocyte-specific chemokines
-
批准号:13671451
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2001
-
负责人:TAKESHIMA Hideo
-
依托单位:
Role of NF2 tumor suppressor gene promoter in the tumorigenesis
-
批准号:11671371
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:1999
-
负责人:TAKESHIMA Hideo
-
依托单位:
国内基金
海外基金
cGAS-STING通路调控单核细胞活化参与Graves病发病的机制研究
-
批准号:82370787
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王曙
-
依托单位:
CCL8介导ALA光动力治疗皮肤鳞状细胞癌的效应与机制研究
-
批准号:81602396
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:吉杰
-
依托单位:
小胶质细胞的IL-6/JAK/STAT3/MCP-1信号途径在MS/EAE发病过程中的作用
-
批准号:81070958
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2010
-
负责人:程琦
-
依托单位: